AIMD

Ainos, Inc. - Common Stock (AIMD)

About Ainos, Inc. - Common Stock (AIMD)

Ainos, Inc. operates as a dual-platform biotech company, which engages in the development of artificial intelligence-enabled olfactory sensing technologies and immune therapeutics. The firm primarily focuses on the commercialization of AI Nose, an AI-based electronic olfaction system. It continues to develop VELDONA, a low-dose oral interferon platform. The company was founded on June 26, 1984 and is headquartered in Houston, TX.

Details

Daily high

$1.56

Daily low

$1.43

Price at open

$1.48

52 Week High

$4.44

52 Week Low

$1.26

Market cap

11.3M

Dividend yield

0.00%

Volume

34,735

Avg. volume

219,490

P/E ratio

-.60

Ainos, Inc. - Common Stock News